- Report
- March 2025
- 183 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- November 2024
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- March 2025
- 94 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- August 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- October 2024
- 197 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Clinical Trials
- April 2024
- 278 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Clinical Trials
- March 2024
- 294 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Clinical Trials
- May 2024
- 114 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Clinical Trials
- March 2024
- 89 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- March 2022
- 300 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Drug Pipelines
- September 2021
- 60 Pages
Global
From €1426EUR$1,500USD£1,198GBP
- Report
- October 2023
- 175 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Clinical Trials
- February 2024
- 83 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Clinical Trials
- February 2024
- 107 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- March 2022
- 304 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Clinical Trials
- October 2020
- 192 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- September 2023
- 119 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- August 2023
- 279 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- April 2023
- 90 Pages
Global
From €2377EUR$2,500USD£1,997GBP

The Metabolic Disorder Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. It includes drugs used to treat metabolic disorders such as diabetes, obesity, and hyperlipidemia. These drugs are used to regulate the body's metabolism, which is the process of converting food into energy. Common drugs used to treat metabolic disorders include insulin, sulfonylureas, biguanides, thiazolidinediones, and GLP-1 agonists. These drugs are used to control blood sugar levels, reduce cholesterol, and promote weight loss.
The Metabolic Disorder Drug market is highly competitive, with many companies offering a variety of drugs to treat metabolic disorders. Some of the major players in the market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. Other companies in the market include Boehringer Ingelheim, Takeda, and Pfizer. Show Less Read more